8-K: MyMD Pharmaceuticals Announces 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing

MyMD Pharmaceuticals has announced a 1-for-30 reverse stock split of its common stock, effective February 14, 2024, to maintain its Nasdaq listing.

Summary

• MyMD Pharmaceuticals has implemented a 1-for-30 reverse stock split of its common stock.
• The reverse stock split was effective at 4:05 p.m. Eastern Standard Time on February 14, 2024.
• The number of outstanding shares decreased from 62,749,125 to approximately 2,091,638, subject to rounding for fractional shares.
• The total authorized shares were reduced from 500 million to 16,666,666.
• The reverse stock split will not change any stockholder's percentage ownership, except for adjustments due to fractional shares.
• Fractional shares resulting from the split will be rounded up to the nearest whole share.
• Trading on a split-adjusted basis began on February 15, 2024, on the Nasdaq Capital Market under the symbol MYMD.
• The CUSIP number for the common stock is now 62856X201.
• Adjustments were made to the exercise price and number of shares for outstanding warrants and convertible preferred stock.
• The company's equity incentive plans will also be adjusted proportionally.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the reverse stock split is a procedural action to maintain listing compliance, not necessarily indicative of positive or negative business performance. It is a necessary step but does not inherently improve the company's prospects.

Positives

• The reverse stock split will help MyMD maintain its listing on the Nasdaq Capital Market.
• The reverse stock split will not change any stockholder's percentage ownership, except for adjustments due to fractional shares.
• Fractional shares will be rounded up to the nearest whole share, benefiting shareholders.

Negatives

• The reverse stock split reduces the number of shares held by each investor.
• The reverse stock split may have a negative impact on the price of MyMD's common stock.

Risks

• The reverse stock split may negatively affect the price of MyMD's common stock.
• The company needs to maintain compliance with Nasdaq listing standards.
• There are risks associated with obtaining and maintaining regulatory approvals for clinical trials.
• The company faces competition and needs to manage its financial resources effectively.
• The company needs to protect its intellectual property and operate without infringing on the rights of others.
• The ongoing COVID-19 pandemic could impact the company's operations and the global economy.

Future Outlook

The company will continue to develop its therapeutic platforms and work towards regulatory approvals for its pharmaceutical candidates. The company disclaims any obligation to revise forward-looking statements.

Management Comments

• The company intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 30 pre-split shares.
• The reverse stock split will become effective at 4:05 p.m. Eastern Standard Time on Wednesday, February 14, 2024.

Industry Context

Reverse stock splits are often used by companies to maintain listing requirements on exchanges like Nasdaq, which can be a common practice for companies facing low share prices. This action is not uncommon in the pharmaceutical industry, especially for clinical-stage companies.

Comparison to Industry Standards

• Reverse stock splits are a common mechanism for companies to regain compliance with minimum share price requirements on exchanges like Nasdaq, similar to actions taken by other companies facing delisting risks.
• The 1-for-30 ratio is a significant split, which is not unusual for companies with very low share prices, and is comparable to other companies that have undertaken similar actions to maintain their listing.
• The adjustments to warrants, preferred stock, and equity awards are standard practice in reverse stock splits to maintain the economic value of these instruments, consistent with industry norms.

Corporate Governance

Stakeholder Impact

• Shareholders will see a reduction in the number of shares they own, but their percentage ownership will remain the same, except for adjustments due to fractional shares.
• The reverse stock split is intended to maintain the company's listing on the Nasdaq, which is important for investor confidence.
• Employees with equity awards will have their awards adjusted proportionally.

Next Steps

• Stockholders holding shares through a brokerage account will have their shares automatically adjusted.
• Stockholders holding physical certificates can exchange them for new certificates, but it is not required.
• The company's transfer agent will handle the exchange of certificates and adjustments to book-entry holdings.

Key Dates

Keywords

reverse stock split, common stock, Nasdaq, MYMD, stock split, equity awards, warrants, preferred stock, shareholder, listing